Literature DB >> 17428875

Epstein-Barr virus thymidine kinase is a centrosomal resident precisely localized to the periphery of centrioles.

Michael B Gill1, Jeffery L Kutok, Joyce D Fingeroth.   

Abstract

The thymidine kinase (TK) encoded by Epstein-Barr virus (EBV) differs not only from that of the alphaherpesviruses but also from that of the gamma-2 herpesvirus subfamily. Because cellular location is frequently a determinant of regulatory function, to gain insight into additional role(s) of EBV TK and to uncover how the lymphocryptovirus and rhadinovirus enzymes differ, the subcellular localizations of EBV TK and the related cercopithecine herpesvirus-15 TK were investigated. We show that in contrast to those of the other family members, the gamma-1 herpesvirus TKs localize to the centrosome and even more precisely to the periphery of the centriole, tightly encircling the tubulin-rich centrioles in a microtubule-independent fashion. Centrosomal localization is observed in diverse cell types and occurs whether the protein is expressed independently or in the context of lytic EBV infection. Surprisingly, analysis of mutants revealed that the unique N-terminal domain was not critical for targeting to the centrosome, but rather, peptide sequences located C terminal to this domain were key. This is the first herpesvirus protein documented to reside in the centrosome, or microtubule-organizing center, an amembranous organelle that regulates the structural biology of the cell cycle through control of chromosome separation and cytokinesis. More recently, proteasome-mediated degradation of cell cycle regulatory proteins, production and loading of antigenic peptides onto HLA molecules, and transient homing of diverse virion proteins required for entry and/or egress have been shown to be coordinated at the centrosome. Potential implications of centrosomal localization for EBV TK function are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428875      PMCID: PMC1900094          DOI: 10.1128/JVI.00147-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8.

Authors:  Coralie Petit; Marie-Lou Giron; Joelle Tobaly-Tapiero; Patricia Bittoun; Eleonore Real; Yves Jacob; Noel Tordo; Hugues De The; Ali Saib
Journal:  J Cell Sci       Date:  2003-08-15       Impact factor: 5.285

2.  The M-PMV cytoplasmic targeting-retention signal directs nascent Gag polypeptides to a pericentriolar region of the cell.

Authors:  Jeffrey N Sfakianos; Rachel A LaCasse; Eric Hunter
Journal:  Traffic       Date:  2003-10       Impact factor: 6.215

3.  Molecular characterization of human ninein protein: two distinct subdomains required for centrosomal targeting and regulating signals in cell cycle.

Authors:  Chang-Han Chen; Shen-Long Howng; Tai-Shan Cheng; Meng-Hui Chou; Chi-Ying Huang; Yi-Ren Hong
Journal:  Biochem Biophys Res Commun       Date:  2003-09-05       Impact factor: 3.575

4.  Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.

Authors:  Huaxin Si; Erle S Robertson
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Virus and cell RNAs expressed during Epstein-Barr virus replication.

Authors:  Jing Yuan; Ellen Cahir-McFarland; Bo Zhao; Elliott Kieff
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

6.  Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein.

Authors:  Jean-Marie Peloponese; Kerstin Haller; Akiko Miyazato; Kuan-Teh Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

7.  Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.

Authors:  Jason S Knight; Nikhil Sharma; Erle S Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-13       Impact factor: 11.205

8.  E1A deregulates the centrosome cycle in a Ran GTPase-dependent manner.

Authors:  Antonio De Luca; Rosamaria Mangiacasale; Anna Severino; Lorenzo Malquori; Alfonso Baldi; Antonella Palena; Anna Maria Mileo; Patrizia Lavia; Marco G Paggi
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

9.  Mortalin-based cytoplasmic sequestration of p53 in a nonmammalian cancer model.

Authors:  Charles Walker; Stefanie Böttger; Ben Low
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

10.  Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles.

Authors:  Marshonna Forgues; Michael J Difilippantonio; Steven P Linke; Thomas Ried; Kunio Nagashima; Jeffrey Feden; Kristoffer Valerie; Kenji Fukasawa; Xin W Wang
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more
  8 in total

1.  The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.

Authors:  Qiao Meng; Stacy R Hagemeier; Joyce D Fingeroth; Edward Gershburg; Joseph S Pagano; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

2.  KSHV-TK is a tyrosine kinase that disrupts focal adhesions and induces Rho-mediated cell contraction.

Authors:  Michael B Gill; Rachel Turner; Philip G Stevenson; Michael Way
Journal:  EMBO J       Date:  2014-12-03       Impact factor: 11.598

3.  Human papillomavirus type 16 E7 oncoprotein associates with the centrosomal component gamma-tubulin.

Authors:  Christine L Nguyen; Catherine Eichwald; Max L Nibert; Karl Münger
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

4.  Epstein-barr virus encodes three bona fide ubiquitin-specific proteases.

Authors:  Ramakrishna Sompallae; Stefano Gastaldello; Sebastian Hildebrand; Nikolay Zinin; Gerco Hassink; Kristina Lindsten; Juergen Haas; Bengt Persson; Maria G Masucci
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

5.  Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells.

Authors:  Xiaoping Sun; Jillian A Bristol; Satoko Iwahori; Stacy R Hagemeier; Qiao Meng; Elizabeth A Barlow; Joyce D Fingeroth; Vera L Tarakanova; Robert F Kalejta; Shannon C Kenney
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

6.  Epstein-Barr virus as a marker of biological aggressiveness in breast cancer.

Authors:  C Mazouni; F Fina; S Romain; L Ouafik; P Bonnier; J-M Brandone; P-M Martin
Journal:  Br J Cancer       Date:  2010-12-21       Impact factor: 7.640

Review 7.  Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways.

Authors:  Peter Wimmer; Sabrina Schreiner
Journal:  Viruses       Date:  2015-08-28       Impact factor: 5.048

8.  Immunoinformatics prediction of potential B-cell and T-cell epitopes as effective vaccine candidates for eliciting immunogenic responses against Epstein-Barr virus.

Authors:  Fisayo A Olotu; Mahmoud E S Soliman
Journal:  Biomed J       Date:  2021-06-19       Impact factor: 4.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.